Off-Label Dosing of Direct Oral Anticoagulants: Prescribing Error or Opportunity in Treating Patients with Atrial Fibrillation?

被引：1
|
作者：
Poli, Daniela [1 ]
机构：
[1] Azienda Osped Univ Careggi, Thrombosis Ctr, Dept Crit Care Med, Viale Morgagni 85, I-40134 Florence, Italy
来源：
THROMBOSIS AND HAEMOSTASIS | 2025年 / 125卷 / 03期
关键词：
EXTENDED TREATMENT; MANAGEMENT; THERAPY;
D O I：
10.1055/a-2441-8902
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：286 / 289
页数：4
相关论文
共 50 条
  • [1] Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients With Atrial Fibrillation
    Sandhu, Amneet
    Kaltenbach, Lisa
    Chiswell, Karen
    Shimoga, Vijay
    Ashur, Carmel
    Pribish, Abby
    Fonarow, Gregg C.
    Piccini, Jonathan P.
    Ho, Michael
    Varosy, Paul D.
    Hess, Paul
    CIRCULATION, 2023, 148
  • [2] OUTCOMES OF OFF-LABEL DOSING OF DIRECT ORAL ANTICOAGULANTS IN MEDICARE BENEFICIARIES WITH ATRIAL FIBRILLATION
    Briasoulis, Alexandros
    Gao, Yubo
    Vaughan-Sarrazin, Mary
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 367 - 367
  • [3] Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients With Atrial Fibrillation in the United States
    Sandhu, Amneet
    Kaltenbach, Lisa A.
    Chiswell, Karen
    Shimoga, Vijay
    Ashur, Carmel
    Pribish, Abby
    Fonarow, Gregg C.
    Piccini, Jonathan P.
    Ho, P. Michael
    Varosy, Paul D.
    Hess, Paul L.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2023, 16 (12): : E010062
  • [4] Off-label direct oral anticoagulants dosing in atrial fibrillation and venous thromboembolism is associated with higher mortality
    Aguilar, Francisco
    Lo, Kevin B.
    Quintero, Eduardo E.
    Torres, Ricardo J.
    Hung, Wikien A.
    Albano, Jeri C.
    Alviz, Isabella
    Rodriguez, Carlos
    Garcia, Mario J.
    Romero, Jorge
    Slipczuk, Leandro
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2021, 19 (12) : 1119 - 1126
  • [5] Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses
    Alexandros Briasoulis
    Yubo Gao
    Chakradhari Inampudi
    Paulino Alvarez
    Rabea Asleh
    Elizabeth Chrischilles
    Enrique C. Leira
    Mary Vaughan-Sarrazin
    BMC Cardiovascular Disorders, 20
  • [6] Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses
    Briasoulis, Alexandros
    Gao, Yubo
    Inampudi, Chakradhari
    Alvarez, Paulino
    Asleh, Rabea
    Chrischilles, Elizabeth
    Leira, Enrique C.
    Vaughan-Sarrazin, Mary
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [7] Patient Characteristics and Predictors of Off-Label versus Standard Dosing of Direct Oral Anticoagulants in Medicare Beneficiaries With Atrial Fibrillation
    Briasoulis, Alexandros
    Gao Yubo
    Vaughan Sarrazin, Mary
    CIRCULATION, 2018, 138
  • [8] How to Demonstrate the Clinical Impact of Off-Label Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation
    Kataoka, Naoya
    Imamura, Teruhiko
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2025,
  • [9] OFF-LABEL USE OF NEW ORAL ANTICOAGULANTS IN ABLATION FOR ATRIAL FIBRILLATION
    Rodriguez, A. V.
    Andres, A. L.
    Villuendas, R.
    Montane, E.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 34 - 34
  • [10] Effectiveness and Safety of Off-Label Dose-Reduced Direct Oral Anticoagulants in Atrial Fibrillation
    Arbel, Ronen
    Sergienko, Ruslan
    Hammerman, Ariel
    Greenberg-Dotan, Sari
    Batat, Erez
    Avnery, Orly
    Ellis, Martin H.
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (07): : 847 - +
12345